Titre : Ergostérol

Ergostérol : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Ergostérol : Questions médicales les plus fréquentes", "headline": "Ergostérol : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Ergostérol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-27", "dateModified": "2025-03-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Ergostérol" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cholestènes", "url": "https://questionsmedicales.fr/mesh/D002782", "about": { "@type": "MedicalCondition", "name": "Cholestènes", "code": { "@type": "MedicalCode", "code": "D002782", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.210.500.247.222" } } }, "about": { "@type": "MedicalCondition", "name": "Ergostérol", "alternateName": "Ergosterol", "code": { "@type": "MedicalCode", "code": "D004875", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yonghui Zhang", "url": "https://questionsmedicales.fr/author/Yonghui%20Zhang", "affiliation": { "@type": "Organization", "name": "Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College , Huazhong University of Science and Technology , Wuhan 430030 , P.R. China." } }, { "@type": "Person", "name": "Tao Feng", "url": "https://questionsmedicales.fr/author/Tao%20Feng", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Applied Microbiology Southern China; Institute of Microbiology, Guandong Academy of Scinces, Guangzhou 510070, China." } }, { "@type": "Person", "name": "Ji-Kai Liu", "url": "https://questionsmedicales.fr/author/Ji-Kai%20Liu", "affiliation": { "@type": "Organization", "name": "School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, China." } }, { "@type": "Person", "name": "Daniel Wüstner", "url": "https://questionsmedicales.fr/author/Daniel%20W%C3%BCstner", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark. Electronic address: wuestner@bmb.sdu.dk." } }, { "@type": "Person", "name": "Daria Derkacz", "url": "https://questionsmedicales.fr/author/Daria%20Derkacz", "affiliation": { "@type": "Organization", "name": "Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Postoperative acute respiratory distress syndrome in randomized controlled trials.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37481422", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.surg.2023.06.019" } }, { "@type": "ScholarlyArticle", "name": "Biological therapies need definitive randomized controlled clinical trials.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36696486", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1126/scitranslmed.adg2970" } }, { "@type": "ScholarlyArticle", "name": "Transparency and reporting characteristics of COVID-19 randomized controlled trials.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36154932", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12916-022-02567-y" } }, { "@type": "ScholarlyArticle", "name": "Preventing diabetes in Latino families: A protocol for a randomized control trial.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37852533", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cct.2023.107361" } }, { "@type": "ScholarlyArticle", "name": "Prehabilitation for general surgery: a systematic review of randomized controlled trials.", "datePublished": "2023-09-07", "url": "https://questionsmedicales.fr/article/37675939", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ans.18684" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés polycycliques", "item": "https://questionsmedicales.fr/mesh/D011083" }, { "@type": "ListItem", "position": 3, "name": "Composés à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072473" }, { "@type": "ListItem", "position": 4, "name": "Stéroïdes", "item": "https://questionsmedicales.fr/mesh/D013256" }, { "@type": "ListItem", "position": 5, "name": "Cholestanes", "item": "https://questionsmedicales.fr/mesh/D002776" }, { "@type": "ListItem", "position": 6, "name": "Cholestènes", "item": "https://questionsmedicales.fr/mesh/D002782" }, { "@type": "ListItem", "position": 7, "name": "Ergostérol", "item": "https://questionsmedicales.fr/mesh/D004875" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Ergostérol - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Ergostérol", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Ergostérol", "description": "Comment détecter l'ergostérol dans un échantillon ?\nQuels tests sont utilisés pour mesurer l'ergostérol ?\nL'ergostérol est-il mesurable dans les tissus humains ?\nQuels symptômes indiquent un déséquilibre d'ergostérol ?\nPeut-on utiliser des biomarqueurs pour l'ergostérol ?", "url": "https://questionsmedicales.fr/mesh/D004875?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Ergostérol", "description": "Quels symptômes sont liés à une carence en ergostérol ?\nL'ergostérol affecte-t-il le système immunitaire ?\nDes symptômes digestifs peuvent-ils être liés à l'ergostérol ?\nL'ergostérol influence-t-il la santé osseuse ?\nPeut-on observer des symptômes neurologiques liés à l'ergostérol ?", "url": "https://questionsmedicales.fr/mesh/D004875?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Ergostérol", "description": "Comment prévenir une carence en ergostérol ?\nDes mesures préventives contre les infections fongiques ?\nL'ergostérol peut-il être un indicateur de santé préventive ?\nQuels aliments sont riches en ergostérol ?\nL'exposition au soleil est-elle essentielle pour l'ergostérol ?", "url": "https://questionsmedicales.fr/mesh/D004875?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Ergostérol", "description": "Quels traitements ciblent l'ergostérol ?\nComment augmenter les niveaux d'ergostérol ?\nDes suppléments d'ergostérol existent-ils ?\nQuels médicaments affectent l'ergostérol ?\nL'ergostérol peut-il être utilisé en thérapie ?", "url": "https://questionsmedicales.fr/mesh/D004875?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Ergostérol", "description": "Quelles complications peuvent survenir avec une carence en ergostérol ?\nL'ergostérol est-il lié à des maladies chroniques ?\nDes complications neurologiques liées à l'ergostérol ?\nComment l'ergostérol affecte-t-il la santé cardiovasculaire ?\nL'ergostérol est-il impliqué dans des infections opportunistes ?", "url": "https://questionsmedicales.fr/mesh/D004875?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Ergostérol", "description": "Quels facteurs augmentent le risque de carence en ergostérol ?\nLes personnes âgées sont-elles à risque d'une carence en ergostérol ?\nLes maladies chroniques influencent-elles les niveaux d'ergostérol ?\nLe mode de vie peut-il affecter l'ergostérol ?\nLes personnes immunodéprimées sont-elles à risque d'infections liées à l'ergostérol ?", "url": "https://questionsmedicales.fr/mesh/D004875?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecter l'ergostérol dans un échantillon ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'ergostérol peut être détecté par chromatographie ou spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour mesurer l'ergostérol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques et des analyses de sang peuvent être utilisés pour mesurer l'ergostérol." } }, { "@type": "Question", "name": "L'ergostérol est-il mesurable dans les tissus humains ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ergostérol peut être mesuré dans les tissus, notamment dans les échantillons de peau." } }, { "@type": "Question", "name": "Quels symptômes indiquent un déséquilibre d'ergostérol ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un déséquilibre peut entraîner des troubles cutanés ou des infections fongiques." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour l'ergostérol ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biomarqueurs spécifiques peuvent aider à évaluer les niveaux d'ergostérol." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une carence en ergostérol ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une carence peut provoquer des problèmes de peau et une susceptibilité accrue aux infections." } }, { "@type": "Question", "name": "L'ergostérol affecte-t-il le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ergostérol joue un rôle dans la modulation de la réponse immunitaire." } }, { "@type": "Question", "name": "Des symptômes digestifs peuvent-ils être liés à l'ergostérol ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles digestifs peuvent survenir en cas de déséquilibre d'ergostérol." } }, { "@type": "Question", "name": "L'ergostérol influence-t-il la santé osseuse ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ergostérol est impliqué dans le métabolisme osseux et la santé des os." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques liés à l'ergostérol ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies neurologiques peuvent être associées à des niveaux anormaux d'ergostérol." } }, { "@type": "Question", "name": "Comment prévenir une carence en ergostérol ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en champignons et une exposition au soleil aident à prévenir la carence." } }, { "@type": "Question", "name": "Des mesures préventives contre les infections fongiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter les environnements humides aide à prévenir les infections." } }, { "@type": "Question", "name": "L'ergostérol peut-il être un indicateur de santé préventive ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, surveiller les niveaux d'ergostérol peut indiquer la santé préventive globale." } }, { "@type": "Question", "name": "Quels aliments sont riches en ergostérol ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les champignons, les levures et certains aliments fermentés sont riches en ergostérol." } }, { "@type": "Question", "name": "L'exposition au soleil est-elle essentielle pour l'ergostérol ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition au soleil est cruciale pour la synthèse de la vitamine D, qui aide à l'ergostérol." } }, { "@type": "Question", "name": "Quels traitements ciblent l'ergostérol ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antifongiques comme l'amphotéricine B ciblent l'ergostérol dans les membranes fongiques." } }, { "@type": "Question", "name": "Comment augmenter les niveaux d'ergostérol ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition au soleil et la consommation de champignons peuvent augmenter les niveaux d'ergostérol." } }, { "@type": "Question", "name": "Des suppléments d'ergostérol existent-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des suppléments d'ergostérol sont disponibles pour soutenir la santé." } }, { "@type": "Question", "name": "Quels médicaments affectent l'ergostérol ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments antifongiques inhibent la synthèse de l'ergostérol dans les champignons." } }, { "@type": "Question", "name": "L'ergostérol peut-il être utilisé en thérapie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ergostérol est étudié pour son potentiel thérapeutique dans diverses conditions." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une carence en ergostérol ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une carence peut entraîner des infections fongiques graves et des problèmes cutanés." } }, { "@type": "Question", "name": "L'ergostérol est-il lié à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux anormaux d'ergostérol peuvent être associés à des maladies chroniques comme le diabète." } }, { "@type": "Question", "name": "Des complications neurologiques liées à l'ergostérol ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres d'ergostérol peuvent contribuer à des troubles neurologiques." } }, { "@type": "Question", "name": "Comment l'ergostérol affecte-t-il la santé cardiovasculaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux d'ergostérol anormaux peuvent influencer la santé cardiovasculaire et le cholestérol." } }, { "@type": "Question", "name": "L'ergostérol est-il impliqué dans des infections opportunistes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence en ergostérol peut augmenter le risque d'infections opportunistes chez les immunodéprimés." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de carence en ergostérol ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation pauvre en champignons et un manque d'exposition au soleil augmentent le risque." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles à risque d'une carence en ergostérol ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru de carence en raison de l'alimentation et de l'exposition." } }, { "@type": "Question", "name": "Les maladies chroniques influencent-elles les niveaux d'ergostérol ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies chroniques peuvent affecter la synthèse et l'absorption de l'ergostérol." } }, { "@type": "Question", "name": "Le mode de vie peut-il affecter l'ergostérol ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent réduire les niveaux d'ergostérol." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles à risque d'infections liées à l'ergostérol ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont plus susceptibles de développer des infections fongiques en raison d'un déséquilibre." } } ] } ] }

Sources (10000 au total)

Postoperative acute respiratory distress syndrome in randomized controlled trials.

Acute respiratory distress syndrome is a potentially fatal postoperative complication. We aimed to estimate temporal trends of the representation of patients with postoperative acute respiratory distr... This is a secondary analysis of 7 randomized controlled clinical trials conducted by the Acute Respiratory Distress Syndrome Network and the Clinical Trials Network for the Prevention and Early Treatm... Out of 5,316 patients with acute respiratory distress syndrome, 256 (4.8%) had postoperative acute respiratory distress syndrome. Representation of postoperative acute respiratory distress syndrome in... Representation of postoperative acute respiratory distress syndrome in trials of the Acute Respiratory Distress Syndrome Network and the Clinical Trials Network for the Prevention and Early Treatment ...

Transparency and reporting characteristics of COVID-19 randomized controlled trials.

In the context of the COVID-19 pandemic, randomized controlled trials (RCTs) are essential to support clinical decision-making. We aimed (1) to assess and compare the reporting characteristics of RCTs... We searched the Cochrane COVID-19 Study Register and L·OVE COVID-19 platform to identify all reports of RCTs assessing pharmacological treatments of COVID-19, up to May 2021. We extracted indicators o... We identified 251 trial reports: 121 (48%) were first published in peer-reviewed journals, and 130 (52%) were first published as preprints. Transparency was poor. About half of trials were prospective... Transparency, completeness, and consistency of reporting of COVID-19 clinical trials were insufficient both in preprints and peer-reviewed publications. A comparison of paired reports published in pre...

Preventing diabetes in Latino families: A protocol for a randomized control trial.

Latino families are disproportionately affected by type 2 diabetes (T2D) and lifestyle intervention is the first-line approach for preventing T2D. The purpose of this study is to test the efficacy of ... Latino families (N = 132) will be recruited and assessed for glucose tolerance as measured by an Oral Glucose Tolerance Test (OGTT) and General and Weight-Specific Quality of Life (QoL) at baseline, f... This study will provide much needed data on the efficacy of a family-focused Diabetes Prevention Program among high-risk Latino families....

Prehabilitation for general surgery: a systematic review of randomized controlled trials.

Prehabilitation seeks to optimize patient health before surgery to improve outcomes. Randomized controlled trials (RCTs) have been conducted on prehabilitation, however an updated synthesis of this ev... This study was registered with PROSPERO (CRD42023403289), and adhered to PRISMA 2020 and SWiM guidelines. PubMed/MEDLINE and Ovid Embase were searched to 4 March 2023 for RCTs evaluating prehabilitati... From 929 records, 36 RCTs of mostly low risk of bias were included. 17 (47.2%) were from Europe, and 14 (38.9%) North America. 30 (83.3%) investigated cancer populations. 31 (86.1%) investigated physi... Prehabilitation interventions showed mixed levels of effectiveness, and there is insufficient RCT evidence to suggest system-level delivery across General Surgery within standardized protocols. Howeve...

Evaluation of ICARUS Guidelines and Recommendations Not Supported by Randomized Controlled Trials.

The ICARUS guidelines are a systematic review and Delphi process that provide recommendations in the treatment and management of patients with gastroesophageal reflux disease (GERD). Many of the recom... Four ICARUS guidelines were chosen: the role of fundoplication for patients with BMI > 35, regurgitation, chest pain, and extra-esophageal symptoms. A multicenter database of patients undergoing fundo... Five institutions performed a fundoplication on 461 patients for GERD with a median of follow-up of 14.7 months (IQR 14.2). On multivariate analysis, patients with the chosen pre-operative comorbiditi... Among the ICARUS guidelines and recommendations, a small proportion was lacking evidence at low risk for bias and endorsement. The results of this multicenter study evaluated outcomes of patients with...

Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials.

Randomized controlled trials (RCTs) may report outcomes different from those prespecified on trial-registration websites, protocols and statistical analysis plans (SAPs). This study sought to investig... MEDLINE via PubMed was searched to include phase II-IV HF RCTs in 9 high-impact journals from 2010 to 2020. Outcomes reported in trial publications were compared with prespecified outcomes in protocol... More than 1 in 10 trials reported outcomes inconsistent with those specified in trial registration websites, SAPs and protocols. An action plan is warranted to minimize selective reporting and improve...

Effects of whole grain intake on glycemic control: A meta-analysis of randomized controlled trials.

Although mounting evidence has suggested an inverse association between the intake of whole grains and glycemic control, findings from randomized controlled trials are still conflicting. The current s... A literature search was carried out to identify qualified studies up to July 2021. The effects of whole grain consumption on glycemic control were calculated using a fixed effects model. Subgroup anal... A total of 32 randomized controlled trials with 2,060 participants were included in the analyses. Whole grain consumption showed a significant inverse regulatory effect on fasting glucose concentratio... Medium-/long-term whole grain intake reduced the fasting glucose concentration compared with similar refined foods. Appropriate intervention dose and accurate population selection might be the key lin...